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This examination consists of two ssctions
SectLon A consists of 50 rnultiple choice questions.
Section B consists of two (2, long questions.
Answer ALLr question.
Answers to section A must be entered j"nto the scripts'provided.
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SectLon A
Mark (/, the answers on the opposite space corresponding to a
correct or most appropriate answer for each question. Each ques-
tion has onJ-y one correct or most appropriate answer or state-
ment.
1. Which of the following is/are compatible with thehistology of Hodgkin' s dl-sease ?
( i ) Lynphocyte predominance.
( il) Nodular sclerosis.
(iii) Mixed cellularlty.
( iv) Lymphocyte depletion.
(a) (i) and (ii) onJ-y.
(b) (i), (ii) and (iii) onty.
(c) (i), (ii), (iii) and 1iv).
(d) 1rv) only.
2. Which of the following statements regarding nausea and
vomiting in a cancer patient is not true ?
(a) It is nore common in patients treated withj-ntravenous rather than oral chemotherapy.
(b) It is more severe in a patient treated with
comblnation of radiotherapy and chemotherapy.
(c) Its severity ls influenced by the type
of anticancer agents"
(d) MesnaR is reserved only for nausea
and vomiting resistant to other antiemetic
agents.
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3. tthich of the following statements regarding heparinis true ?
(a) It is not recommended to be used for more
than 24 hours.
(b) It has no effect on the intrinsic
coagulation sYstem.
(c) It ls not safe to administer bY
intermittent subcutaneous injection.
(d) It requires only a smaLl dose to prevent
thrombin formation.
4. hlhlch of the foll"owing statements regarding leukemials/are true?
(i) Acute lymphocytic leukemia occurs mainly in
chlldren.
(fi) Chronic leukemLa occurs malnly in adult above
4O years of age.
(iii) chronic lymphocytic leukemia is twice as common
as chronJ-c granulocytic leukemia.
1fv) Chronj-c l-eukemia affects women more than itdoes man.
{a) (i) and (ii) only are true.
(b) (i), (ii) and (iii) only are true.
(c) (i), (li), (iii) and (iv) are true.
(d) (iv) only is true.
(FCP ss7)
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5. Which of the following statements regarding acute
- myeloblastic leukenia as compared to acute lymphoblastic
leukemia islare true?
(i) It requires central nervous system (CNS)prophylaxis.
(ii) The prognosis is worse for boys.
( ii-i ) It has a worse Prognosis.
1fv) Onty tot who goes into remission are "cured"'
(a) {1) and (1i) onJ-Y are true.
(b) (t), (ii) and (lii) only are true.
(c) (i), (il), (iit) and (iv) are true.
(d) 1iv) only is true'
6. Which of the foLlowing i-slare ctinical feature(s) of chronicgranulocytJ-c leukemia ?
( i ) Fever.
.( ii ) Haemorrhage.
( iii ) Cqrt.
( lv) Prlaplsm.
(a) (i) and (ii) onlY.
(b) (i), (ii) and (ili) onIY.
(c) (i), (ii), (ii.i) and (iv).
(d) (iv) only.
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7. Whlch of the following problems lslare assoclated withfaetor VIII replacement therapy ?
(i) DeveJ.opment of antibody to factor VIII.
(if) Development of antibody to factor Ix.
(lii) Acute hepatitis.
(iv) Allergic reaction.
(a) (j-) and (il) only
(b) (i), (ii) and (iii) on1y.
..... (c) (i), (ii), (ili) and (iv).
( d) 1 rv) on]"y.
8. WhLch of the following clotting factors is/are involved
with intrinsj-c clotting mechanism?
(i) xr.
( ri ) xrr.
( ili ) rx.
( lv) VII.
(a) (i) and (ii) only.
(b) (i), (ii) and (iii) on].y.
(c) (i), (ii), (iii) and (iv).
(d) (lv) on1y.
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the following abnormaLities
Prolonged prothrombin time'
Prolonged PTT.
Low platelets.
Low fibrinogen degradation
(FCP 557)
islare found in DIC9. lrlhich of
(i)
(il)
(iii)
( iv) products (FDP).
(a) (i) and (il) onIY.
(b) (i), (ii) and (lil) onlY.
(c) (t), (ii), (iii) and 1iv).
(d) (iv) onJ.y.
LO. Which of the following conditions occur(s) .in rnyeJ-oma ?
(i) Pathological fracture of the vertebrae-
(il) Hypocalcemia.
( tii ) Arnyloidosis
(iv) Thrombocytosis.
(a) (i) and (ii) onlY.
(b) (i), (ii) and (iii) on1y.
(c) (i), (ii), (iti) and (iv)'
(d) (iv) on1y.
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1.1. Which of the following is/are diagnostlc feature(s)
of myeloma ?
(1) Monoclonal band on serum electrophoresj-s.
(if) Skull X-ray showing multiple punched-out lesions.
(iif ) Bone mamow showing plasma cell infiltration.
(lv) Pseudohyponatraemia.
(a) (i) and (ii) only.
(b) (i), (1r) and (il.l) only.
(c) (t), (ii), (lLi) and 1iv),
(at) (iv) only.
L2. Which of the following statements regarding the spread
of breast cancer is/are true?
(i) It is by dl.rect local extenslon.
(il) It occurs by embolization through l.ymphatics.
(ifi) It occur. by hematogenous spread.
(iv) It can be prevented by radlotherapy.
..... (a) (i) and (ii) only are true.
..... (b) (i), (ii) and (lli) only are true.
..... (c) (i), (ii1, (l.iL) and (iv) are true.
(d) (iv) only is true,
...8/_
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1"3. Irlhich of the following islare used to clinical-ly divldebreast cancer ?
(i) Invasive ductal carcinoma.
( fi I Medu1lary carcinoma.
(111) Paget's disease of the nipple.
(Iv) Breast abscess.
(a) (i) and (ii) onlY.
(b) (i), (il) and (iit) onlY.
(c) {i), (ii), (iii) and (lv).
(d) (iv) only.
1,4. Which of the following is/are treatnent modality(ies) forbreast carcinona ?
(1) Radiotherapy.
(ii) OvariectomY.
(iii) Stilbesterol administration.
( iv ) Fl-utemide administration.
(a) (i) and (ir) onIY.
(b) (i), (ir) and (iij-) only.
(c) (i), (ii), (tii) and 1iv).
(FcP s57) I
(d) (iv) only.
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15. Which the following statements regarding bronchial
carcinoma is/are true?
(i) It responds to radiotherapy.
(li) It has a better prognosis than small-cell
carcinoma of the lung.
(iii) It presents as chest pain.
(iv) It rarely causes hemoptysis.
(a) {1) and (if) only are true.
(b) (i), {ii) and (iii) on]-y are true.
{c) (i), (li), (ili) and (iv) are true.
td) (iv) only is true.
58. lrlhich of the folLowing factors predisposes the patient tothromboernboLisfi ?
{a) Protein M deficiency.
{b) Congestive heart fal-Iure,
(c) Diabetes mellitus.
(d) Thalassemia.
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I?. lrlhich of the following islare true regarding treatment
of lung cancer ?
(i) Chemotherapy is curative.
(ii) Radiotherapy is useful for oat-cell carcinoma"
(tii) Hormonal manipulation ls a mode of treatment.
(iv) Surglcal resectlon is useful for early
bronchLal carcinoma.
(a) (i) and (ii) onlY are true.
(b) (i), (ii) and (iii) only are true'
(c) (i), (ii), (lii) and 1fv) are true'
(d) (iv) onlY is true.
18. Which of the follOwing condS-tions is an absolute
contraindication to thrombolytic therapy ?
(a) Postpartum Period,
(b) Thoracocentesis,
(c) Recent serious trauma.
(d) Active internal bleeding.
(FCP 55? ) I
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L9. Which of the followlng statements concerning prostate
carcinoma Ls/are true ?
(i) Bone secondarles can be seen on plain abdominal
X-rays.
(fi) Radiotherapy I-s a mode of treatment forpainful secondarle.e.
(iJ.l) Low serum acid phosphatase is diagnostl-c.
(J.v) Per-reetal examination elicits soft prostate.
(a) (i) and (fl) only are true.
(b) (i), (ii) and (ili) onLy are true.
(c) (i), (i1), (lii) and (iv) are true.
(d) (iv) only is true.
24. Whlch of the following statements regarding treatment
of prostate carclnoma is,/are true ?
(i) Transuretheral resection of the prostate is to
relieve obstrtiction.
(ii) teutenl,stng nornone releasing hormone (LHRH)
analogue Ls r.rsed as a treatment.
(iii) Orchiectomy is useful in some cases.
(iv) Cytotoxic drugs are effectlve for secondaries.
(a) (i) and (ii) only are true.
(b) {i), (fi) and (i11} only are true.
(c) (i), (ii), (lii) and 1rv) are true.
(d) (iv) only is true,
:5.11
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2L. Which of the following is/are the treatment(s) for
colorectal cancer ?
( 1) SurgLcal. removal.
(lf) s-FU and LevamLsol'
(ili) Radiotherapy of the primary tumor.
(iv) Immunotherapy.
(a) (i) and (ii) onIY.
(b) (i), (li) and (iit) onIY.
(c) (i), (li), (iii) and 1fv).
ZZ. Whlch of the following is appropriate to minimize Iocal and
maJor hemorrhage ln patients recelving thronbolytic
therapy ?
(a) Increased physical handling of patient.
(b) Use subcutaneous or intramuscular injectonsfor parenteral medications.
(c) Avoidance of concurrent use of dextran.
(d) Avoidance of compression bandages at sites of
vessel Punture.
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23. Which of the followlng statements concerning colorectal
cancer is/are true ?
(i) Serum carcino-embryoni-c antigen is ralsed in
the presence of metastasis.'
( il ) Raised aJ-kal1ne phosphatase l"ndicates liver
or bony secondaries.
(lii) Colonoscopy is useful for determlning
a second tumor site.
1iv) The prognosls is poor if the patient J.syoung'
(a) (1) and (ii) only are true.
(b) (i), (1i) and (i11) only are true.
(c) (i), (fi), (iii) and (lv) are true.
(d) (iv) only is true.
24. Which of the foLlowing condltions may cause hypochromj-c
anaemia ?
(1) Thalassaemia.
(ii) Lead poisonlng.
(111) Pregnancy.
(iv) Heredltary spherocytosis.
(a) (i) and (1i) only.
(b) (1), (li) and (ili) only.
(c) {i), (ii), (iii) and (iv).
(d) (iv) only.
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25. Which of the following conditions will j'ncrease the mean
corpuscular volume (MCV)?
( i ) Thalasiaeml-a.
(if) Anaemia of chronic renal failure'
(iii) HaemolYsis.
(iv) Folate deficlencY.
(a) (i) and (l-i) onIY.
(b) (1), (ii) and (iil) onlY.
(c) (i), (ii), (iit) and 1rv)'
(d) 1iv) onIY
26. Which of the following statements regarding iron absorpti-onis/are true?
ti)Ferrouscompoundsisabsorbedbetterthanferric
comPound.
(ii) Absorptlon is enhaneed when the pH of the small
bowel ls low or neutral'
(iii) Phytate-rioh green ln vegetables enhances iron
absorPtion.
{lv) Vitarnin C inhibits absorption'
(a) (i) and (ii) onlY are true'
(b) (i), (ii) and (tii) on].y are true'
(c) (i), (ii), (iii) and (iv) are true'
(d) (iv) onIY is true.
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27, Which of the foLlowlng conditions cause{s) anaemia with
splenomegaly in a chlld ?
(1) Thalassaemia.
(li ) Congenltal spherocytosls.
(ili, BLz deflciency.
(iv) Folate deficiency.
(a) (i) and (ii) only.
(b) (i), (il) and (ili) onty.
(c) (i), (il), (lii) and 1rv).
(d) (iv) only.
28. Which of the foLlowLng condltions cause(s) fotatedeficiency ?
(i) Sustained boll-tng of food containing fol"ate.
. 
(li) AdministratLon of a broad spectrum antibiotic.
(iti) Rapid eells growth.
1 fv) Methotrexate therapy.
(a) (i) and (ii) only.
(b) (i), (ir1 and (iii) onty.
(c) (i), (if), (iii) and (iv).
(d) {iv) only,
E{ qtrIt,
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29. Whlch of the fotlowLng statements regarding heparin is
true ?
(a) It crosses the Placenta
(b) It can lead to toxlcity in a breast fed baby'
(c) The risk of bleeding complicatlon increases vrith
the J-ength of theraPY.
. (d) Protease l-s the drug of choice for the reversal
of, heParin effect.
30. Ethich of the following conditions stimulate
erythroPoiesis ?
(i) Anaemia.
(11) Hypoxia"
(iii) High altitude.
(lv) Reduced erythropoietin in the blood.
(a) (i) and (ii) on1Y.
(b) (i), (ii) and (iir) onlY.
(c) (i), (ii), (lii) and (iv).
(d) (iv) only.
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31. Which of the following statements regarding heparin
therapy is true ?
(a) It does not cause thrombocytopenia.
(b) Prolonged treatment can lead to osteoporosis.
(c) The therapeutic range for APTT test should be3-4 tlmes control.
,.... (d) Intravenous therapy for deep vein thrombosls
requires 24-48 hours duration.
32. Which of the following drugs increases anti-coagulation
effect of wafarin ?
(a) Allopurinol.
(b) Carbamazepine.
(d) Griseofulvin.
517
...L8/-
(FcP 5s7) t
- l_8
INDEX NO:
33. Which of the followLng islare feature(s) of
slderobl-astic anaemia ?
(i) The anaemia is hypochromic and microcytic'
(ii) Increased serum ferrltin.
( iii ) Bone maffow showing increased sideroblast cells.
(1v) Very high Level of haemoglobin F (HbF)'
(a) (i) and (i1) onIY.
(b) (t), (ii) and (lii) onLy.
(c) (i), (ii), (ili) and 1iv).
(d) 1iv) only.
34. Which of the foll-owing thrombolytic agents has thehighest antigenicitY ?
(a) StrePtokinase
(b) Urokinase
(c) Tissue plasrninogen activator (rtPA)
r: r,. (d) Anysoylated plasminoEen streptokinase activator
comPlex (APSAC).
518
. 
" 
.L91-
1.9 (FCP 557)
INDEX NO:
35. Which of the following islare consistent with iron
deficLency anaemia ?
(f) Low mean corpuscular haemoglobln (MCH).
(li) Hypochromlc and microcytic red blood ceJ-}s.
(iii) High retLculocytes count.
(iv) Htgh serum ferrltin.
(a) (i) and (ii) only.
(b) (1), (ii) and (lii) only'
(c) (i), (ii), (lii) and (iv).
(d) 1iv) on1y.
36. lrlhlch of the following disorders islare associated with
hypochromia?
(i) Thalassaemia.
(ii) Folate deficient.
(iiI ) BLZ deficlent.
1 :-v ) Sideroblastic anaemia.
(a) (i) and (ii) on1y.
(b) (i), (il) and (iti) onl-y.
(c) (i), (ii), (iii) and (lv).
(d) 1iv) only.
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37, Whlch of the following statements regarding haemoglobin
normar chirdren is'/are true?
(i) Haemoglobin F contains alpha-2 de1ta-2'
(ii) HaemogJ,obin contains heme and globin portions.
(iii) The level of traemoglobin A2 is higher than
haemoglobin AL.
1iv) The tevel of haemoglobin F is high'
(a) (i) and (ii) onlY are true.
(b) (i), (ii) and (iii) only are true.
(c) {i), (il), (iii) and 1fv) are true.
(d) liv) only is true.
38. whlch of the following w111 decrease production of redblood cells?
ti) Iron deficiencY.
(ii) FolLc acid deficiencY.
(iii) Malnutrition.
(lv) Aplastic anaemia.
(a) (i) and (ii) onlY.
(b) (i), (ii) and (iii) onlY.
{c) (i), (il),. (iii) and (iv).
(d) 1iv) onIy.
520
...2L/-
(FCP 557)
INDEX NO:
39, Which of the followinE statements regarding
beta-thalassaemia is/are true?
(i) There is a short red blood celI survival.
(ii) Splenomegaly is a feature.
(1it) FlypersplenJ.sm is a recognJ-sed complication.
1fv) Frequent blood transfuslons have no harmful
slde-effects.
(a) (i) and (ii) only are true.
(b) (i), (ii) and (ili) only are true.
(c) (i), (ii), (iii) and (lv) are.true.
(d) (tv) only is true.
40. WhJ.ch of the following condl-tions is/are complication(s)
of beta-thalassaemia maJor ?
(i) Short stature.
(fl) Hypersplenism.
( ilI ) DJ.abetes mellitus.
(tv) Poor school performance.
(a) (i) and (ii) only.
{b) (i), (ii) and (iii) on1y.
(c) (i), (ii), (iii) and (iv).
(d) (iv) only.
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4L. Which of the following is/are consistent with the clinicalfeatures of thalassaemia ?
(i) Failure to thrive in early childhood.
(ii) Masslve hepatosplenomegaly.
(l-j.i) Pallor.
1fv) Severe Jaundice.
(a) (1) and (ii) onIY'
(b) (i), (ii) and (iii) onIY.
(c) (i), (li), (iil) and (iv).
(d) (j"v) only.
42. Which of the following statements regarding the use of
anticancer drugs is/are true ?
(i) Comblnation of 2 drugs with similar mechanism
of actlon is recolr,mended.
(1i) Conbination of 2 oncovin group is recommended
to reduce the dose of each drug.
(l^l.i) The ratlonale of combination chemotherapy 1s
to achieve rapid cytotoxic activity.
1fv) Each druE in a combination therapy mustpossess activity against the treated cancer-
(a) (i) and (ii) only are true.
(b) (i), (ii) and (iii) only are true.
(c) (i), (il), (lii) and (lv) are true.
(d) (1v) only is true.
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43. lrlhich of the following statements regard:lng the use ofhydration therapy ln patlents treated with anticancer
agents J-s/are true ?
(i) Pre- and post-hydratlons are used to avoid
nephrotoxicity
( ii ) Pre- and post-hydratl-ons are
volume of distribution of the
(iii) Pre- and post-hydrations are
hepatotoxlcJ-ty.
1fv) Pre- and post-hydrations are
clearence of the drugs.
(FCP 557)
used to increase the
drugs.
used to prevent
used to increase the
(a) (i) and (il) only are true.
(b) (1), (1i) and (iii) only are true.
(c) (t), (1i), (lii) and (iv) are true.
(d) (iv) only is true.
44. Which of the following statements regardi.ng the use of
allopurinol in patients treated with antlcancer drugsls,/are true ?
(1) It prevents excesslve production of urJ.c acid.
(il) It avoids gouty arthritis.
(iii) It im.proves the clearance of uris acid.
(iv) rt lncreases urine'output.
(a) (i)
(b) ( i),
(c) (i),
(d) 1iv)
and (1i) only are true.
(1i) and (ili) only are true.
(if), (lii) and 1fv) are true.
only is true.
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45. Which of the following statements regarding the use of
antibiotics in febrile neutnopenic patients is/are true ?
(a) (i) and (ii) only are true.
(b) (i), (ii) and (iil) only are true.
(c) (i), (ii), (ij-i) and 1iv) are true.
(d) (iv) only is true.
46. Which of the following statements regarding the use
of arnphoteracin B in febrile neutropenic pati-entis,/are true ?
(i)
(ii)
(ril)
(lv)
(i)
(ii)
(1ii)
(iv)
The combination of aminoglycosi-de and
cephalosporJ-n combination is the best empirlc
therapy.
Vancomycin is only added when the patlent do not
respond to the combination of aminoglycoside
and cephalosporin.
The use of bacteriostatic agent should be
discouraged.
A combination of lmipenem and a cephalosporS-nis the best alternatlve for pseudomonas lnfection.
It is usually reserved for patient withliver failure.
It is safe ln a dehydrated Patlent.
Itsr ease of admlnistration is an advantage
over the other antifungal agents.
It should only be started after seven days ofpersistent fever desplte antibiotic therapy.
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(a) (i) and (ii) onJ.y are true.
(b) (i), (ii) and (iii) only are true.
(c) (i), (il), (ll.i) and (iv) are true.
(d) (iv) only is t:rue.
47. WhJ-ch of the followlng condltions requires treatment
with combj-nation of trimethoprim-sulfa'soxazole,
nystatln and lactacyd bath?
(a) AlL neutropenic non-febrile patient.
(b) AlJ- febrile cancer patients.
(c) A11 neutropenic febrile patients.
(d) AII 4on-febrile cancer patients.
48. Which of the foJ.lor"rinE groups of cancer patients are
suitable for therapy wlth vancomycin ?
(a) AlI neutropenic febrile patients.
(FCP ss7)
tb) Neutropenic febrile patients who do not respondto a combinatlon of arninoglycoside and
cephalosporin therapy.
(c) Neutropenic febrile patients who do not respond
to amphoteracin B therapy.
(d) Neutropenic febrile patients with severe
mucositis.
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(a) Pediatrio cancer patients treated with
cycloposphamide.
(b) Pediatric cancer patients treated wlth
cis-platinum.
(c) Pediatric cancer patients treated with
bleomycin.
(d) Pediatric cancer patients treated with
methotrexate.
50. Which of the followlng conditions has its risk reduced
by proper hydration ?
(a) Nephrotoxiclty.
(b) Bladder toxicity.
{c) Hepatotoxlcity.
(d) Myelosupression.
(FCP 557)
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Section B
Question 1
OP is a 6 year old boy diagnosed to fiave osteosarcoma on tfie leftleg on January 15, 1994. The dlagnosis was confirmed by CT scan
and blopsy. His doctor plans to administer high dose methotrexateprior to amputation.
LZ gm/m2 of methotrexate was given weekly for four weeks followed
by folinic acid rescue (L5 mg IV every 6 hourly for l-0 doses) 
"4hours after each methotrexate dose. A pre- and post-hydrationprotocol was also followed during every methotrexate dosing.
a. Explain why OP required pre- and post-hydration therapy ?
{2.5 marks )
One week after amputatlon of the affected J.eg, post operative
Lnduction therapy using BCD protocol was Lnitiated as follows:
Bleomycin L5 U/nZ on Dl, and D2
Cyclophosphamide 600 mg/m2, Dl. and D2
Actlnomycin 6O0 ugm/m2, Dl and D2
During thls phase of treatment, 3 L/m2/d of IV fluids were
administered.
b. What Ls the purpose of hydration therapy in thLs phase of
BCD protocol ?
(2.5 marks )
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On day 2 of the BCD Protocol,
site of infusion. The nurse
at the Lnfusion site.
-28
OP complained of
in-charge noticed
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severe pain at the
a large echymosis
d,
c. ExplaJ-n the posslble cause of the paj-n and echymosis ?
( 5 marks )
Briefly expJ.a1n the steps that shoul-d be taken to treat
OP's problems ?
(5 marks)
Flve days after the second dose of BCD, OP developed a high gradefever. His full blood picture showed neutropenia with a neu-
trophJ-l count of O.
e. Br{efly explain how you would manage OPrs fever.
(10 marks)
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guestion 2
MN is a 50 year o1d Indlan male who came to the clinic after
had noted suprapubic pain and burning sensation on urination.
Laboratory investigation revealed a hemogtobin of L4.0 gm/dl,hematocrit of 43.6t, white bl-ood cel-J. count af 7,5O0 /rnm3 and
reticulocyte of 0.5t. Serum electrolytes, bilirubin andprothrombin time were al-1 within normal ll-mits.
Urinalysls showed 2O to 5O cells per hLgh power field and
rnoderate bacteria colonization.
A provisional diagnosis of eystitis related to benign prostatic
hypertrophy was made.
Hls urine was sent for culture and sensitivity and Septra DS one
tablet BID was instituted.
Four days later MN returned to the cllnic complaining of feellng
very tired although his origlnal symptoms had resol-ved, He also
noted that his urine had become dark.
Physical examination was unremarkable except for icteric scJ.era
and a mild tachycardia.
Follow up laboratory investigations revealed a hemoglobln of 9.0gm,/dl, trematocrit cf 3O.5t, whi.te blood cell count of 9,L00,/mm3,
reticulocyte count of 1Lt, total bilirubin of 3.8 mg/dl, directbilirubl-n of 4.7 mg/dL. Urinal-ysis now revealed no bacteria, a
4+ blood and O-l- red cells/high power field. The urine was alsopositive for biliribin and urobilLnogen.
a. Ho!', was the clinical picture of MN compatib]-e with
drug-lnduced hemolysis due to G6PD deficlency ?
( 3 Marks )
...30/_
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How did the clinlca1 presentation of MN differ from
autoimmune hemoJ.ytic anaemia? Compare and contrast the
mechanLsm invol-ved for both type of hemolytic anaemia ?
( 6 Marks
c. How can MN's G6PD deficiency be treated ?
( 4 Marks )
B. MS is a 38 year old 7O kg Malay male with a five-year history
of ulcerative colltis. He developed a swollen left calf which
was painful and $rarm. .This swelling gradually increased, affect-ing the entlre left leg up to the groJ"n. Several days later, h€
noted a right-slded pleuritic chest paI-n but without shortness ofbreath or hemoptysis
His past rnedical history ineluded a gastric ulcer treated medi-
cally wl-thout recurrence.
PhysLcaJ- eximination:
Obese male with an enlarged left Ieg and nild to moderate tender-
ness in the entire leg. Chest examination revealed a loud pulmo-
nary heart sound,
BP: 150/85 mmHg, PR: LoO/min, RR: 28lmin.
Laboratory data:Hct: 26.7, ESR: 91 mm/hr.
ABG: pH t 7.48
POZ z 72 mmHg.pCoZ : 35 mmllg.
Chest X-ray, 3-ung scan and VQ scans were highly suggestive of
pulmonary embolism.
ECG shows sinus tachycardia. Venogram was positive for the
presence of a defect in the ileo-femoral artery.
Coagulation tests:
PT LL.Z sec.
aPTT 28 sec.Platelate 248,00o/mm3
a. What subJectlve and objective evidence in MS was compatible
with pulmonary embolism ?
s30
( 4 marks )
...3L/-
c. Describe how would you monitor MS's heparin therapy ?
-31
b. How do you lnLtiate heparln regimen in MS ?
(FCP 557)
( 4 marks
( 4 marks
531
...32/-
Appendix
1. Ammonia
2. Amilase
3. BilllrubinDirect
Indirect
TotaI
4. CaZ
5. pCoZ
6. Cr
7. Cpk
8. Creatinfne (SCr)
9. Random blood sugar
10. Iron
L1. Lactic
dehydrogenase
12. Magnessium
13. Poz
L4. pH
L5. Acid PhosPhatase
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Normal LaPqratorY Vq1uee
O-0.2 ng/gL
A.2-O.8 ngldf
O.2-L mg/dL
20-30 mEq/L
35-45 mmHg
100-106 mEq/L
5O-t7O v/L
O.6-L.5 mg/dl
7O-110 mg/dl
50-150 mcg/dl
7A-2LO rV/L 
.
L.5-2.O mEq/L
75-LOO mmHg
7.35-7.45
8O-1LO mcg/dl or 47-65 umol/L
4-25 Iulml
(FCP 557)
O-3 umol/L
30-L4 umol/L
30-17 umol/L
24-3CI mMoI/L
100-106 rnMol/L
60-130 umol/L
3-10 umol/L
9 .0-26.9 umol/L
O.8-1.3 mMo]"ll.,
Male 0.13-0.63 IUlmIFemale 0.101-0.65 lUlnL
16. AlkaLine 39-1L7 ]:u/L
phosphatase
1.7. Phosphorous 3.0-4.5 ng/dl
18. Potassium (K+) 3.5-5.0 mEq/t
L9. calcium (ca?+) 8.5-10.5 mg/dl
20. Sodium ( tta+ ) 135-145 tnEq/L
2L. BLcarbonate (HCO3- | 24'38 mEq/L
36-L76 nmol 
=-1l"2.8-156 nmol s''/L
1. O-1.5 mMol/L
3.5'5.0 mMol/L
2.L-2.6 mMol,/L
135-145 mMol/L
24-28 mMoI/L
...33/-
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Total 6.0-8.5 g/ar 6O-85 g/L
- Albumin 3.5-5.O g/dl 35-50 g/rGlobulin 2.3-3.5 g/dL 23-35 g/LTransferrin 200-4OO mgldt 2.O-9.a g/t
23. Transamlnase O-40 IU/L 0-0.32 umol u-L /t
( scor )
24. BUN 8-25 mgldI 2.9-8.9 mMol/L
25. Uric Acid 3-7 mg/d3- O.LB-O .42 mMoL/L
26. Blood PLctures
Red blood ceII (RBC)Male 4.8-6.4 x 109/mm:Female 4.2-5.4 x Loo/mrnr AWhite blood cell(WBC) 4.0-11.0 x 105/mmrP 60-75tL 2A_40*M 4-88B O-18E L-3*
Plate1ate (plt, 2OO-4OO x 103/mm3
2?. ESR MaIe O-1O mm,/Jam (Wintrobe)Female O-15 mm,/Jam (lfintrobe)
28. Hematocrit
MaIe 4S-SZ*Female 37-48*
29. Hemoglobine lHgb)MaIe 1"3-18 g/d\Fema1e L2-L6 g/dt
30. ProthrombLn time 75-1OOt nilai asas(PT)
31. APTT 25-32 saat
32. Creatl-nine 105-150 mt/rn J-n/L.73 mZClearance
( CrCl )
33. TT4 3.0-7.5 mcgldl
34. RT3U 25-35t
35. FTr L.3-4.2
. .34/ -
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NORMAL HEMODYNAMIC VALUES AND DERIVED INDICES
Normal Va1ue Units
BP s/D/ttt 3i:?3rilffi;::;.tic/Mean Lza/80/es mm Hg
co cardtac output 4-6 Liters/min.
IAP Right Atrlal Pressure( Mean ) 2-6 mrn Hg
pAp s/D/M Pulmonary Artery Pressure 25/L2/L6 mrn Hg
SystoI ic,/Di astol iclMean
PCWP Pulmonary Capillary Wedge 5-L2 mm Hg
Pressure (mean)
cI Cardiac Index 2.5-3.5 Liters/min/m2
CI=
Body Surface Area
SV Stroke Volume 60 - g0 mllbeat
SV=
Heat Rate
SvI Stroke Volume Index 30 - 50 m;-lbeat/m2
SVI
SVI=
Body Surface Area
PVR PulmonarY Vascular
Resistance
MPAP - PCWP
PVR= x80
co
rPvR t";::t:::i33erar vascular 
eoo-1400 dvnes.sec."*-5
MBP 
- 
RAP
TPVR x80
TVSWI Left Ventricular Stroke .
Work Index 35-80 gm-m/m" / beat
LvSwI = (MBP-PCWP)(svl)( .0136)
< 2OO dynes.sec.o*-S
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